The dramatic footage was almost impossible to miss. A torrent of water tearing through Gyirong …
Read More »Risk profile tool provides clearer insight on hospitalized COVID-19 patients who benefit most from baricitinib treatment
Credit: CC0 Public Domain A post-hoc analysis of ACTT-2 (Adaptive COVID-19 Treatment Trial-2) found that the use of a risk profile may more precisely characterize high-risk patients who may benefit from the use of baricitinib. The analysis is published in Annals of Internal Medicine. ACTT was a series of large, …
Read More »












































